Sort
53,477 grants matching “addiction”
Peripherally-restricted and long-acting kappa-opioid receptor (LA-KOR) agonists for pain
$1,524,027Pierre Riviere · Peptide Logic, Llc · R44 · FY2018 · DA
Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse
$1,522,479Chang-Guo Zhan · University Of Kentucky · UH3 · FY2017 · DA
Medication Development for the Treatment of Alcohol Use Disorder
$1,521,805Susan E. Bergeson · Texas Tech University Health Scis Center · U01 · FY2020 · AA
Non-pharmacological Options in postoperative Hospital-based And Rehabilitation pain Management (NOHARM) pragmatic clinical trial
$1,521,299Andrea Lynne Cheville · Mayo Clinic Rochester · UH3 · FY2020 · AG
C57BI/6 Mouse Lines Expressing CRE-Recombinase in the Nervous System
$1,521,168Ulrich Mueller · Scripps Research Institute, The · U01 · FY2008 · MH
Characterization of neuronal ensembles activated during drug-induced behavior
$1,519,811Bruce Hope · National Institute On Drug Abuse · ZIA · FY2011 · DA
Yale/NIDA Neuroproteomics Center
$1,519,226Kenneth Robert Williams · Yale University · P30 · FY2016 · DA
A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.
$1,519,167Fredric Schiffer · Mindlight, Llc · R44 · FY2022 · DA
New approaches to addiction treatment
$1,518,640David Epstein · National Institute On Drug Abuse · ZIA · FY2020 · DA
DRUGS OF ABUSE -- ROLE OF PROTEIN PHOSPHORYLATION
$1,517,475Paul Greengard · Rockefeller University · P01 · FY2006 · DA
Quantitative Assessment of Pelvic Floor Muscle Fitness in Myofascial Pelvic Pain
$1,516,765A. Lenore Ackerman · University Of California Los Angeles · R61 · FY2024 · AT
Center for the Neurobiology of Addiction Treatment
$1,516,519Steven R Childers · Wake Forest University Health Sciences · P50 · FY2009 · DA
Yale/NIDA Neuroproteomics Research Center
$1,514,432Kenneth Robert Williams · Yale University · P30 · FY2008 · DA
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$1,512,886Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2025 · AI
Corticostriatal mechanisms of action learning and habit formation
$1,512,160David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2018 · AA
Biological And Biochemical Characterization Of Sigma Receptors
$1,511,954Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2022 · DA
Optimizing HIV-care-continuum engagement and outcomes among opioid users
$1,511,604David Epstein · National Institute On Drug Abuse · ZIA · FY2018 · DA
Optimizing HIV-care-continuum engagement and outcomes among opioid users
$1,511,604David Epstein · National Institute On Drug Abuse · ZIA · FY2019 · DA
OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23)
$1,510,879Jennifer McCormack · The Emmes Company, Llc · N01 · FY2024 · DA
Genomewide Association Study of Cocaine Dependence in two Populations
$1,510,652Joel Gelernter · Yale University · RC2 · FY2010 · DA
Innovative Approaches for Cocaine Pharmacotherapy
$1,510,494Helen M Pettinati · University Of Pennsylvania · P50 · FY2009 · DA
Quantifying Exposure to Illicit Drugs & Psychosocial Stress in Real Time
$1,510,400Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2013 · DA
Quantifying Exposure to Illicit Drugs & Psychosocial Stress in Real Time
$1,509,833Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2012 · DA
Molecular Genetic Bases for Quit Success
$1,509,084George R Uhl · National Institute On Drug Abuse · ZIA · FY2009 · DA
Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse
$1,508,665David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA